Nephro Care India Ltd.

NSE: NEPHROCARE

SME

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

83.00-3.0 (-3.43%)

23 Oct, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Nephro Care India Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR
Total Revenue	1.82	3.42	17.09	27.23	46.03	88.73
Cost of Operating Revenue	1.25	1.59	5.75	9.61	15.52	31.45
Gross Profit	0.57	1.83	11.34	17.62	30.51	57.28
Gross Margin	31.4	53.4	66.4	64.7	66.3	64.6
Total Operating Expenses	1.68	3.41	14.45	21.28	42.54	84.81
Operating Profit	0.14	0.01	2.64	5.95	3.49	3.93
Operating Margin	7.8	0.4	15.5	21.8	7.6	4.4
Financing Income/(Expense) - Net	-0.02	-0.02	-0.06	0.18	1.13	0.39
Profit before Taxes	0.12	0.00	2.58	6.22	4.83	4.64
Income Taxes	0.03	0.01	0.20	1.72	1.19	1.27
Profit after Tax	0.09	-0.01	2.37	4.41	3.64	3.37
PAT Margin	4.9	-0.3	13.9	16.2	7.9	3.8
EPS - Basic - ex Extraordinary Items	0.05	-0.01	1.44	2.68	2.38	2.04
EPS - Diluted - ex Extraordinary Items	0.05	-0.01	1.44	2.68	2.38	2.04
EBIT	0.14	0.01	2.64	5.95	3.49	3.93
EBITDA	0.15	0.13	3.43	6.47	5.95	9.00
EBITDA Margin	8.5	3.7	20.0	23.8	12.9	10.1

Balance Sheet

Abridged

Understanding Balance Sheet

Nephro Care India Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	AR	AR	AR	AR
Total Current Assets	0.52	1.08	2.94	4.40	28.24	30.79
Long-Term Investments	0.10	0.03	2.00	6.51	2.58	1.75
Property Plant & Equipment - Net	0.51	3.29	3.01	5.59	32.08	34.44
Total Non-Current Assets	0.61	3.55	5.32	16.57	40.05	41.93
Total Assets	1.13	4.63	8.26	20.97	68.28	72.72
Total Current Liabilities	0.48	1.65	3.29	5.86	14.03	15.28
Long Term Debt	0.63	2.46	2.44	-	-	-
Total Non-Current Liabilities	0.63	2.49	2.44	0.08	0.77	0.54
Total Liabilities	1.11	4.13	5.73	5.94	14.80	15.82
Total Shareholders' Equity	0.01	0.50	2.53	15.03	53.48	56.85
Minority Interest	-	-	-	-	-	0.05
Total Equity	0.01	0.50	2.53	15.03	53.48	56.90
Total Liabilities & Equity	1.13	4.63	8.26	20.97	68.28	72.72

Cash Flow

Abridged

Understanding Cash Flow Statement

Nephro Care India Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.16	0.05	3.32	4.19	5.34	7.68
Working Capital - Increase/(Decrease)	0.05	0.56	0.80	-3.28	2.64	-5.37
Net CF from Operating Activities	0.21	0.61	4.11	0.91	7.98	2.30
Capital Expenditures - Net	0.07	2.89	0.50	3.29	29.80	7.81
Net CF from Investing Activities	-0.07	-2.82	-2.33	-7.54	-39.72	-0.53
Stock - Issuance/(Retirement) - Net	-	0.49	-	0.10	4.58	-
Debt - LT & ST - Issuance/(Retirement) - Total	0.30	1.84	-0.07	-2.48	-	-
Net Cash Flow from Financing Activities	0.30	2.33	-0.07	5.60	35.10	0.05
Free Cash Flow to Equity	0.44	-0.44	3.54	-4.86	-21.82	-5.50
Free Operating CF net dividend	0.14	-2.28	3.61	-2.38	-21.82	-5.50
Free Operating CF	0.14	-2.28	3.61	-2.38	-21.82	-5.50

Business Segment Analysis

FY End:

Mar 26

Nephro Care India Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Income frome IPD services (48.7%)₹ 43.30 CrIncome from OPD (28.4%)₹ 25.19 CrIncome from sale of medicines from pharmacy (22.9%)₹ 20.36 Cr

Assets

Income frome IPD services (44.7%)₹ 32.47 CrOthers (40.1%)₹ 29.16 CrPharmacy (9.1%)₹ 6.60 CrIncome from OPD (6.2%)₹ 4.50 Cr

Regional Segment Analysis

Nephro Care India Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Nephro Care India Ltd.

Historical Segment Analysis

Track how Nephro Care India Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31
Healthcare services	0	3	1	3

Frequently Asked Questions

What is the revenue of Nephro Care India Ltd.?

The latest trailing twelve month revenue of Nephro Care India Ltd. is ₹ 88.73 Cr, reflecting a 1-year growth of 92.77% and a 3-year CAGR of 73.15%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Nephro Care India Ltd.?

The latest trailing twelve month net profit (PAT) of Nephro Care India Ltd. is ₹ 3.37 Cr, with a 3-year earnings CAGR of 20.08%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Nephro Care India Ltd.?

The trailing twelve month EBITDA of Nephro Care India Ltd. is approximately ₹ 3.25 Cr (based on an operating margin of 3.66%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Nephro Care India Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Nephro Care India Ltd. is 2.04. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Nephro Care India Ltd.?

The debt-to-equity ratio of Nephro Care India Ltd. stands at 0.00. The interest coverage ratio is 20.48x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Nephro Care India Ltd.?

The estimated book value per share of Nephro Care India Ltd. is 34.49 (derived from a P/B ratio of 2.41 and market price of ₹ 83.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Nephro Care India Ltd.?

The trailing twelve month operating cash flow of Nephro Care India Ltd. is ₹ 2.30 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Nephro Care India Ltd. report consolidated or standalone financials?

Nephro Care India Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.